BCL6 and plasma cell neoplasm: Moreover, immunohistochemical profiling revealed distinct expression patterns—such as elevated PD1 and CD56, and altered BCL6 expression—in clonal cases, which may serve as useful biomarkers for early recognition of plasma cell neoplasm transformation in AITL patients.